BioFluidica
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $3.5M
Investors
- 1
About BioFluidica
Based in California, US, and founded in 2006, BioFluidica, Inc. is a biotechnology company developing a diagnostic platform allowing for disease management and diagnosis. Steven A. Soper is the co-founder of the company, and Rolf Muller serves as its CEO. In February 2022, BioFluidica, Inc. The company develops a liquid biopsy platform that allows for the separation and analysis of all liquid biopsy biomarkers on a single completely automated platform, including cells, exosomes, and cfDNA. The Biofluidica platform has been clinically verified on 9 distinct cancer and pregnant patient samples, and it is being used for a wide range of research applications in the field of liquid biopsy.
Who invested in BioFluidica
1 investor across 1 round
See all investors in BioFluidica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 19, 2021
Amount
$3.5M
Investors
Questions about BioFluidica
Who invested in BioFluidica?
BioFluidica has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioFluidica raised?
BioFluidica has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioFluidica last raise money?
BioFluidica's most recent round on record is a Series B, in Nov 2021.
What does BioFluidica do?
Based in California, US, and founded in 2006, BioFluidica, Inc.
Where is BioFluidica headquartered?
BioFluidica is headquartered in Lawrence, US.
Which VCs invest in companies like BioFluidica?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BioFluidica's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like BioFluidica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.